0001062993-23-021913.txt : 20231205
0001062993-23-021913.hdr.sgml : 20231205
20231205161143
ACCESSION NUMBER: 0001062993-23-021913
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231201
FILED AS OF DATE: 20231205
DATE AS OF CHANGE: 20231205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grade Joel T.
CENTRAL INDEX KEY: 0001602507
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-04448
FILM NUMBER: 231466702
MAIL ADDRESS:
STREET 1: SYSCO CORPORATION
STREET 2: 1390 ENCLAVE PARKWAY
CITY: HOUSTON
STATE: TX
ZIP: 77077
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BAXTER INTERNATIONAL INC
CENTRAL INDEX KEY: 0000010456
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 360781620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE BAXTER PKWY
STREET 2: DF2-1W
CITY: DEERFIELD
STATE: IL
ZIP: 60015
BUSINESS PHONE: 8479482000
MAIL ADDRESS:
STREET 1: ONE BAXTER PARKWAY
STREET 2: DF2-1W
CITY: DEERFIELD
STATE: IL
ZIP: 60015
FORMER COMPANY:
FORMER CONFORMED NAME: BAXTER TRAVENOL LABORATORIES INC
DATE OF NAME CHANGE: 19880522
FORMER COMPANY:
FORMER CONFORMED NAME: BAXTER LABORATORIES INC
DATE OF NAME CHANGE: 19760608
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-12-01
0000010456
BAXTER INTERNATIONAL INC
BAX
0001602507
Grade Joel T.
ONE BAXTER PARKWAY
DEERFIELD
IL
60015
0
1
0
0
EVP and CFO
0
Common Stock, $1 par value
2023-12-01
4
A
0
27988
0
A
27988
D
Common Stock, $1 par value
2023-12-01
4
A
0
25189
0
A
53177
D
Stock Option (Right to Buy)
36.55
2023-12-01
4
A
0
102273
0
A
2033-12-01
Common Stock, $1 par value
102273
102273
D
The reporting person received a restricted stock unit grant which is scheduled to vest in three equal annual installments beginning on December 2, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
The reporting person received a restricted stock unit grant which is scheduled to vest in three equal annual installments beginning on December 2, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
The options become exercisable in three equal annual installments beginning on December 2, 2024, the first anniversary of the grant date.
/s/ Matthew Rice, as attorney in-fact for Joel T. Grade
2023-12-05